Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer

Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer

Abstract Background Tumor necrosis factor (TNF) has been investigated to be correlated with the occurrence and progression of lung cancer. This investigation was to assess the efficacy and safety of recombinant mutant human tumor necrosis factor (rmhTNF) for controlling malignant pleural effusion (M...

Full description

Bibliographic Details
Main Authors: Tian Fu, Yong Lin, Qingdi Zeng, Wei Yao, Liping Han
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Pulmonary Medicine
Subjects:
Recombinant mutant human tumor necrosis factor
RmhTNF
Malignant pleural effusion
Lung cancer
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12890-020-01210-x

Internet

http://link.springer.com/article/10.1186/s12890-020-01210-x

Similar Items